DATA
Data di pubblicazione: 02/11/2020
AUTORI
NANYONJO GERTRUDE
ASIKI GERSHIM
SSETAALA ALI
NAKAWEESA TEDDY
WAMBUZI MATHIAS
NANVUBYA ANNET
MPENDO JULIET
OKECH BRENDA
KITANDWE PAUL KATO
NIELSEN LESLIE
NALUTAAYA ANNET
WELSH SABRINA
BAGAYA BERNARD SSENTALO
CHINYENZE KUNDAI
FAST PAT
PRICE MATT
KIWANUKA NOAH
ENTE DI AFFERENZA
UVRI IAVI HIV VACCINE PROGRAM LTD
AFRICAN POPULATION & HEALTH RSCH CTR NAIROBI KENYA
MRC UVRI & LSHTM UGANDA RSCH ENTEBBE UGANDA
PARTNERSHIP FOR RSCH ON EBOLA VIRUS IN LIBERIA PREVAIL MONROVIA LIBERIA
MAKERERE UNIV COLLEGE OF HEALTH SCIENCES UGANDA TUBERCULOSIS & IMPLEMENTATION RSCH CONSORTIUM KAMPALA UGANDA
HUMAN VACCINES PROJECT NEW YORK NY USA
DEPT IMMUNOLOGY & MOLECULAR BIOLOGY SCHOOL OF BIOMEDICAL SCIENCES COLLEGE OF HEALTH SCIENCES MAKERERE UNIV KAMPALA UGANDA
IAVI NEW YORK NY USA
DEPT EPIDEMIOLOGY & BIOSTATISTICS UNIV CALIFORNIA AT SAN FRANCISCO SAN FRANCISCO CA USA
DEPT EPIDEMIOLOGY & BIOSTATISTICS SCHOOL OF PUBLIC HEALTH COLLEGE OF HEALTH SCIENCES MAKERERE UNIV KAMPALA UGANDA
RIVISTA
The Pan African Medical Journal, 37, 208